Details of the Drug
General Information of Drug (ID: DMH8QWY)
Drug Name |
2-oxo-N-phenyl-2H-chromene-3-carboxamide
|
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
2-oxo-N-phenyl-2H-chromene-3-carboxamide; NSC375104; 2-oxo-N-phenylchromene-3-carboxamide; 54396-25-7; AC1L7UQ9; Oprea1_247443; Oprea1_472798; CBDivE_011982; JMC521935 Compound 6; SCHEMBL831792; IFLab1_001129; CHEMBL494795; NIOSH/DJ2267500; Coumarin, 3-(anilinocarbonyl)-; BDBM23543; ZINC42178; DTXSID80321427; MolPort-000-375-218; HMS1415D07; (2-oxochromen-3-yl)-N-benzamide; 3-Carboxamide-coumarin deriv., 18; STK337557; AKOS000511884; 2-oxo-N-phenyl-chromene-3-carboxamide; NSC-375104; MCULE-7275389335; IDI1_008996
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Drug Type |
Small molecular drug
|
|||||||||||||||||||
Structure | ||||||||||||||||||||
3D MOL | 2D MOL | |||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 265.26 | ||||||||||||||||||
Topological Polar Surface Area (xlogp) | 3 | |||||||||||||||||||
Rotatable Bond Count (rotbonds) | 2 | |||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | |||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | |||||||||||||||||||
Chemical Identifiers |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
|||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||||||||
References